Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide is a synthetic small molecule belonging to the class of proline derivatives. It features a pyrrolidine core with a carboxamide group, substituted at the nitrogen with a 4-carbamimidoylbenzyl moiety and at position 1 with a cyclopentyloxyethanoyl group. The compound has been referenced in chemical databases but there is no evidence of clinical development, approved therapeutic use, or detailed mechanism of action in humans. Its structure suggests potential as an experimental protease inhibitor or related research tool, but no specific biological target or indication is confirmed in public sources[1][2][4].
- Other names
- (2S)-N-[(4-carbamimidoylphenyl)methyl]-1-[2-(cyclopentyloxy)acetyl]pyrrolidine-2-carboxamide(2S)-N-((4-carbamimidoylphenyl)methyl)-1-(2-(cyclopentyloxy)acetyl)pyrrolidine-2-carboxamideN-(4-carbamimidoylbenzyl)-1-[(cyclopentyloxy)acetyl]-L-prolinamide
Beyond the preview
Go deeper on (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide.